Recall
FDAHealthJuly 13, 2026

Major Pharmaceuticals — Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianap

⚠️ Subpotent Drug

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
July 13, 2026

Nationwide in the USA.

What's affected?

Product
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61
Lot code
N02310

Additional details

Lot #: N02310, Exp. Date 01/2027

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: N/A.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.